Management of congenital adrenal hyperplasia. Urinary steroid estimations--review of their value.
AffiliationChristie Hospital, Withington, Manchester, M20 4BX, UK
MetadataShow full item record
AbstractA retrospective study was made of 16 children with 21-hydroxylase-deficient congenital adrenal hyperplasia of the salt-losing variety, who were treated with fludrocortisone and prednisone and were in good health during the period under review. The height velocity of the children was subnormal, height achievement was poor, and their bone ages retarded. Urinary 17-oxosteroid and pregnanetriol excretion were used to monitor the therapy of the children and these data have been related to growth velocities. In spite of urinary steroid figures in excess of those published as desirable for monitoring therapy, the children failed to grow properly, probably as a result of glucocorticoid overdosage. Published urinary steroid criteria are considered too strict and in order to achieve them one would need to give unnecessarily high doses of steroid. Regular measurement of height velocity and skeletal maturation rate are better indicators of therapeutic control and should lead to more satisfactory growth and ultimate height.
CitationManagement of congenital adrenal hyperplasia. Urinary steroid estimations--review of their value. 1978, 53 (2):132-5 Arch. Dis. Child.
JournalArchives of Disease in Childhood
- Growth and skeletal maturation in congenital adrenal hyperplasia. Review of 20 cases.
- Authors: Bailey CC, Komrower GM
- Issue date: 1974 Jan
- Congenital adrenal hyperplasia and diabetes mellitus in a woman aged 71 years.
- Authors: Hoff W van't, Bicknell EJ
- Issue date: 1972 Feb
- Experience with long-term therapy in congenital adrenal hyperplasia.
- Authors: Brook CG, Zachmann M, Prader A, Mürset G
- Issue date: 1974 Jul
- Blood testosterone values in patients with congenital virilizing adrenal hyperplasia.
- Authors: Solomon IL, Schoen EJ, Donelan L, Brandt-Erichsen D
- Issue date: 1975 Mar
- Treatment of congenital virilizing adrenal hyperplasia patients with single and multiple daily doses of prednisone.
- Authors: Huseman CA, Varma MM, Blizzard RM, Johanson A
- Issue date: 1977 Apr